Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Kuzel

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Oncology (Williston Park, N.Y.)|June 15, 2007
Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapyChristiane Querfeld, Timothy M Kuzel, Joan Guitart, et al.
Current Cancer Drug Targets|August 22, 2002
Diphtheria fusion protein therapy of chemoresistant malignanciesArthur E Frankel, Patrick Rossi, Timothy M Kuzel, et al.
Immunotherapy|December 18, 2013
Requirement of NK cells for selective A2A receptor blockade to suppress CD73+ tumor metastasisLei Qin, Linda F Thompson, Timothy M Kuzel, et al.
Current Treatment Options in Oncology|February 8, 2012
Cutaneous T-cell lymphomas: a review of new discoveries and treatmentsTara Bloom, Timothy M Kuzel, Christiane Querfeld, et al.
American Journal of Clinical Pathology|December 20, 2007
The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndromeKatalin Kelemen, Joan Guitart, Timothy M Kuzel, et al.
Hematology/Oncology Clinics of North America|January 9, 2004
High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphomaYu Oyama, Joan Guitart, Timothy M Kuzel, et al.
Expert Opinion on Pharmacotherapy|April 26, 2006
Bexarotene in the treatment of cutaneous T-cell lymphomaChristiane Querfeld, Lakshmi V Nagelli, Steven T Rosen, et al.
Urology|April 4, 2008
Metastatic renal cell carcinoma with partial response to sunitinib complicated by ureteral obstruction from necrotic tumorJoshua J Meeks, Kathrine A Kasper, Ximing Yang, et al.
Melanoma Research|March 19, 2014
Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experienceKhairuddin Memon, Timothy M Kuzel, Michael Vouche, et al.
Cancer Investigation|August 29, 2002
Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancerTimothy M Kuzel, Merrill S Kies, Nini Wu, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Oncology (Williston Park, N.Y.)|June 15, 2007
Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapyChristiane Querfeld, Timothy M Kuzel, Joan Guitart, et al.
Current Cancer Drug Targets|August 22, 2002
Diphtheria fusion protein therapy of chemoresistant malignanciesArthur E Frankel, Patrick Rossi, Timothy M Kuzel, et al.
Immunotherapy|December 18, 2013
Requirement of NK cells for selective A2A receptor blockade to suppress CD73+ tumor metastasisLei Qin, Linda F Thompson, Timothy M Kuzel, et al.
Current Treatment Options in Oncology|February 8, 2012
Cutaneous T-cell lymphomas: a review of new discoveries and treatmentsTara Bloom, Timothy M Kuzel, Christiane Querfeld, et al.
American Journal of Clinical Pathology|December 20, 2007
The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndromeKatalin Kelemen, Joan Guitart, Timothy M Kuzel, et al.
Hematology/Oncology Clinics of North America|January 9, 2004
High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphomaYu Oyama, Joan Guitart, Timothy M Kuzel, et al.
Expert Opinion on Pharmacotherapy|April 26, 2006
Bexarotene in the treatment of cutaneous T-cell lymphomaChristiane Querfeld, Lakshmi V Nagelli, Steven T Rosen, et al.
Urology|April 4, 2008
Metastatic renal cell carcinoma with partial response to sunitinib complicated by ureteral obstruction from necrotic tumorJoshua J Meeks, Kathrine A Kasper, Ximing Yang, et al.
Melanoma Research|March 19, 2014
Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experienceKhairuddin Memon, Timothy M Kuzel, Michael Vouche, et al.
Cancer Investigation|August 29, 2002
Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancerTimothy M Kuzel, Merrill S Kies, Nini Wu, et al.
Pageof 12